Rape and Sexual Coercion Related Pregnancy in the United States.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 22 06 2023
revised: 01 11 2023
accepted: 02 11 2023
medline: 23 2 2024
pubmed: 8 11 2023
entrez: 7 11 2023
Statut: ppublish

Résumé

Sexual violence is a major public health problem in the U.S. that is associated with numerous health impacts, including pregnancy. U.S. population-based estimates (2010-2012) found that three million women experienced a rape-related pregnancy during their lifetimes. The current study presents more recent estimates of rape and sexual coercion-related pregnancy and examines prevalence by demographic characteristics. Data years 2016/2017 were pooled from the National Intimate Partner and Sexual Violence Survey, a random-digit-dial telephone survey of U.S. non-institutionalized adults 18 years and older. The analysis, conducted in 2023, examined lifetime experience of rape-related pregnancy, sexual coercion-related pregnancy, or both among U.S. women. Authors calculated prevalence estimates with 95% CIs and conducted pairwise chi-square tests (p-value<0.05) to describe experiences by current age, race/ethnicity, and region of residence among U.S. women overall and among victims. One in 20 women in the U.S., or over 5.9 million women, experienced a pregnancy from either rape, sexual coercion, or both during their lifetimes. Non-Hispanic Multiracial women experienced a higher prevalence of all three outcomes compared with non-Hispanic White, non-Hispanic Black, and Hispanic women. Among victims who experienced pregnancy from rape, 28% experienced a sexually transmitted disease, 66% were injured, and over 80% were fearful or concerned for their safety. Pregnancy as a consequence of rape or sexual coercion is experienced by an estimated six million U.S. women. Prevention efforts may include healthcare screenings to identify violence exposure and use of evidence-based prevention approaches to reduce sexual violence.

Identifiants

pubmed: 37935321
pii: S0749-3797(23)00442-7
doi: 10.1016/j.amepre.2023.11.001
pmc: PMC10951889
mid: NIHMS1977096
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-398

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Am J Prev Med. 2018 Dec;55(6):770-776
pubmed: 30361141
JAMA. 2018 Oct 23;320(16):1678-1687
pubmed: 30357305
Am J Obstet Gynecol. 1996 Aug;175(2):320-4; discussion 324-5
pubmed: 8765248
J Womens Health (Larchmt). 2021 Feb;30(2):230-235
pubmed: 33181043
Women Health. 2020 Nov-Dec;60(10):1174-1184
pubmed: 32835639
J Trauma Stress. 2022 Oct;35(5):1484-1496
pubmed: 35765157
Health Psychol. 2019 Nov;38(11):997-1000
pubmed: 31259595
J Consult Clin Psychol. 2022 Mar;90(3):209-220
pubmed: 35201781
J Obstet Gynaecol. 2008 Apr;28(3):266-71
pubmed: 18569465
Violence Against Women. 2009 Feb;15(2):133-47
pubmed: 19126832
MMWR Morb Mortal Wkly Rep. 2019 Nov 08;68(44):999-1005
pubmed: 31697656
J Womens Health (Larchmt). 2017 Aug;26(8):828-835
pubmed: 28402692
J Forensic Leg Med. 2021 Apr;79:102136
pubmed: 33631709
J Womens Health (Larchmt). 2019 Mar;28(3):363-374
pubmed: 30335574
Child Maltreat. 2016 Feb;21(1):26-36
pubmed: 26627838
J Interpers Violence. 2021 Dec;36(23-24):NP12504-NP12520
pubmed: 31971055
J Interpers Violence. 2021 Nov;36(21-22):NP12324-NP12341
pubmed: 31808711
J Womens Health (Larchmt). 2021 Feb;30(2):236-244
pubmed: 33295844
Arch Sex Behav. 2022 May;51(4):2241-2259
pubmed: 35622076
J Interpers Violence. 2022 Jul;37(13-14):NP10938-NP10961
pubmed: 33527866
Trauma Violence Abuse. 2018 Oct;19(4):371-390
pubmed: 27535921
Obstet Gynecol. 2012 Feb;119(2 Pt 1):412-7
pubmed: 22270317
Infant Ment Health J. 2019 Sep;40(5):624-639
pubmed: 31314924

Auteurs

Denise V D'Angelo (DV)

Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: DDAngelo@cdc.gov.

Yang Liu (Y)

Division of Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Kathleen C Basile (KC)

Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Sharon G Smith (SG)

Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Jieru Chen (J)

Division of Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Norah W Friar (NW)

Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Mark Stevens (M)

Division of Injury Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH